{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:17:07Z","timestamp":1790115427362,"version":"4.0.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.kint.2023.05.024","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T03:16:06Z","timestamp":1686885366000},"page":"542-551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["A nationwide cohort study comparing the effectiveness of diuretics and calcium channel blockers on top of renin-angiotensin system inhibitors on chronic kidney disease progression and mortality"],"prefix":"10.1016","volume":"104","author":[{"given":"Anne-Laure","family":"Faucon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard L.","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Stengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faizan","family":"Mazhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Jes\u00fas","family":"Carrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2023.05.024_bib1","article-title":"Extracellular fluid volume is an independent determinant of uncontrolled and resistant hypertension in chronic kidney disease: a NephroTest cohort study","volume":"7","author":"Vidal-Petiot","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.kint.2023.05.024_bib2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/joim.13151","article-title":"Trajectory of extracellular fluid volume over time and subsequent risks of end-stage kidney disease and mortality in chronic kidney disease: a prospective cohort study","volume":"289","author":"Faucon","year":"2021","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.kint.2023.05.024_bib3","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.kint.2019.06.017","article-title":"Extracellular fluid volume is associated with incident end-stage kidney disease and mortality in patients with chronic kidney disease","volume":"96","author":"Faucon","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2023.05.024_bib4","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1053\/j.ajkd.2013.06.011","article-title":"Association of fluid overload with kidney disease progression in advanced CKD: a prospective cohort study","volume":"63","author":"Tsai","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2023.05.024_bib5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2215\/CJN.03610414","article-title":"Association of fluid overload with cardiovascular morbidity and all-cause mortality in stages 4 and 5 CKD","volume":"10","author":"Tsai","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.05.024_bib6","article-title":"Volume overload and adverse outcomes in chronic kidney disease: clinical observational and animal studies","volume":"4","author":"Hung","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.kint.2023.05.024_bib7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/1471-2369-15-189","article-title":"Association between ratio of measured extracellular volume to expected body fluid volume and renal outcomes in patients with chronic kidney disease: a retrospective single-center cohort study","volume":"15","author":"Tai","year":"2014","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.kint.2023.05.024_bib8","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1046\/j.1523-1755.2003.00273.x","article-title":"Role of excess volume in the pathophysiology of hypertension in chronic kidney disease","volume":"64","author":"Vasavada","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2023.05.024_bib9","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.kint.2020.10.026","article-title":"Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease","volume":"99","author":"Cheung","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2023.05.024_bib10","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.kint.2019.04.032","article-title":"Considerable international variation exists in blood pressure control and antihypertensive prescription patterns in chronic kidney disease","volume":"96","author":"Alencar de Pinho","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2023.05.024_bib12","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.kint.2023.05.024_bib13","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1681\/ASN.2007060693","article-title":"Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan","volume":"19","author":"Vogt","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.05.024_bib14","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1681\/ASN.2004060505","article-title":"Diuretic and enhanced sodium restriction results in improved antiproteinuric response to RAS blocking agents","volume":"16","author":"Esnault","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.05.024_bib15","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1093\/ndt\/gfp776","article-title":"Diuretic uptitration with half dose combined ACEI\u00a0+ ARB better decreases proteinuria than combined ACEI\u00a0+ ARB uptitration","volume":"25","author":"Esnault","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2023.05.024_bib16","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/ndt\/13.7.1682","article-title":"The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide","volume":"13","author":"Buter","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2023.05.024_bib17","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S2213-8587(14)70030-0","article-title":"Effects of sodium restriction and hydrochlorothiazide on RAAS blockade efficacy in diabetic nephropathy: a randomised clinical trial","volume":"2","author":"Kwakernaak","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.kint.2023.05.024_bib18","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/ki.2015.249","article-title":"Diverse diuretics regimens differentially enhance the antialbuminuric effect of renin-angiotensin blockers in patients with chronic kidney disease","volume":"88","author":"Morales","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2023.05.024_bib19","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1159\/000493268","article-title":"Effect of strict volume control on renal progression and mortality in non-dialysis-dependent chronic kidney disease patients: a prospective interventional study","volume":"27","author":"Esmeray","year":"2018","journal-title":"Med Princ Pract"},{"key":"10.1016\/j.kint.2023.05.024_bib20","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ki.2008.102","article-title":"Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study","volume":"73","author":"Bakris","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2023.05.024_bib21","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1093\/ndt\/gfq565","article-title":"Effect of furosemide on left ventricular mass in non-dialysis chronic kidney disease patients: a randomized controlled trial","volume":"26","author":"Zamboli","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2023.05.024_bib22","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1161\/HYPERTENSIONAHA.120.16117","article-title":"Association of blood pressure variability and diuretics with cardiovascular events in patients with chronic kidney disease stages 1-5","volume":"77","author":"Gregg","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.kint.2023.05.024_bib23","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1001\/jama.285.21.2719","article-title":"Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial","volume":"285","author":"Agodoa","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.kint.2023.05.024_bib24","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2215\/CJN.07800811","article-title":"Long-term renal and cardiovascular outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants by baseline estimated GFR","volume":"7","author":"Rahman","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.05.024_bib25","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(09)62100-0","article-title":"Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial","volume":"375","author":"Bakris","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2023.05.024_bib26","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","article-title":"Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients","volume":"359","author":"Jamerson","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2023.05.024_bib27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1751-7176.2011.00564.x","article-title":"A\u00a0pilot study comparing furosemide and hydrochlorothiazide in patients with hypertension and stage 4 or 5 chronic kidney disease","volume":"14","author":"Dussol","year":"2012","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.kint.2023.05.024_bib28","first-page":"CD003654","article-title":"Calcium channel blockers versus other classes of drugs for hypertension","volume":"1","author":"Zhu","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.kint.2023.05.024_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-048442","article-title":"Renal outcomes of diabetic patients treated with combination therapy of ACE inhibitors plus either thiazide diuretics or calcium channel blockers: comparative retrospective cohort study in Northwestern Ethiopia","volume":"11","author":"Netere","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.kint.2023.05.024_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159335","article-title":"Chronic kidney disease, fluid overload and diuretics: a complicated triangle","volume":"11","author":"Khan","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2023.05.024_bib31","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.amjhyper.2004.12.007","article-title":"Is population-wide diuretic use directly associated with the incidence of end-stage renal disease in the United States? A hypothesis","volume":"18","author":"Hawkins","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.kint.2023.05.024_bib32","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2215\/CJN.09510817","article-title":"Add-on antihypertensive medications to angiotensin-aldosterone system blockers in diabetes: a comparative effectiveness study","volume":"13","author":"Schroeder","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.05.024_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-048755","article-title":"Loop and thiazide diuretic use and risk of chronic kidney disease progression: a multicentre observational cohort study","volume":"12","author":"Fitzpatrick","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.kint.2023.05.024_bib34","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0140-6736(00)02527-7","article-title":"Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT)","volume":"356","author":"Brown","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2023.05.024_bib35","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available","volume":"183","author":"Hern\u00e1n","year":"2016","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.kint.2023.05.024_bib36","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/ckj\/sfaa242","article-title":"Pharmacoepidemiology for nephrologists (part 2): potential biases and how to overcome them","volume":"14","author":"Fu","year":"2021","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2023.05.024_bib37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.kint.2022.09.020","article-title":"Defining measures of kidney function in observational studies using routine health care data: methodological and reporting considerations","volume":"103","author":"Carrero","year":"2023","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2023.05.024_bib38","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1093\/ndt\/gfs461","article-title":"New primary renal diagnosis codes for the ERA-EDTA","volume":"27","author":"Venkat-Raman","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2023.05.024_bib39","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1097\/HJH.0000000000003168","article-title":"Blood pressure and kidney outcomes in patients with severely decreased glomerular filtration rate: a nationwide observational cohort study","volume":"40","author":"Al-Sodany","year":"2022","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.kint.2023.05.024_bib40","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/ndt\/gfz212","article-title":"Major adverse renal events (MARE): a proposal to unify renal endpoints","volume":"36","author":"Prischl","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2023.05.024_bib41","doi-asserted-by":"crossref","first-page":"l5657","DOI":"10.1136\/bmj.l5657","article-title":"Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners","volume":"367","author":"Desai","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.kint.2023.05.024_bib42","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/sim.8471","article-title":"A\u00a0causal framework for classical statistical estimands in failure-time settings with competing events","volume":"39","author":"Young","year":"2020","journal-title":"Stat Med"},{"key":"10.1016\/j.kint.2023.05.024_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.gloepi.2022.100080","article-title":"A\u00a0practical guide to handling competing events in etiologic time-to-event studies","volume":"4","author":"Mansournia","year":"2022","journal-title":"Global Epidemiol"},{"key":"10.1016\/j.kint.2023.05.024_bib44","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1470-2045(21)00033-4","article-title":"Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis","volume":"22","author":"Copland","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.kint.2023.05.024_bib45","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2023.05.024_bib46","doi-asserted-by":"crossref","first-page":"f5680","DOI":"10.1136\/bmj.f5680","article-title":"Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials","volume":"347","author":"Ninomiya","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.kint.2023.05.024_bib47","doi-asserted-by":"crossref","first-page":"610","DOI":"10.7326\/M18-1037","article-title":"Kidney damage biomarkers and incident chronic kidney disease during blood pressure reduction: a case-control study","volume":"169","author":"Zhang","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.kint.2023.05.024_bib48","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1161\/CIRCULATIONAHA.117.030112","article-title":"Worsening renal function in patients with acute heart failure undergoing aggressive diuresis is not associated with tubular injury","volume":"137","author":"Ahmad","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2023.05.024_bib49","doi-asserted-by":"crossref","first-page":"I122","DOI":"10.1016\/0002-9149(89)90969-7","article-title":"Effects of amlodipine on renal hemodynamics","volume":"64","author":"Loutzenhiser","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.kint.2023.05.024_bib50","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2174\/1573402110666140131160617","article-title":"Renal microcirculation and calcium channel subtypes","volume":"9","author":"Homma","year":"2014","journal-title":"Curr Hypertens Rev"},{"key":"10.1016\/j.kint.2023.05.024_bib51","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/archinte.165.8.936","article-title":"Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"165","author":"Rahman","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.kint.2023.05.024_bib52","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(88)91851-X","article-title":"Raised venous pressure: a direct cause of renal sodium retention in oedema?","volume":"1","author":"Firth","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2023.05.024_bib53","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/01.HYP.0000114571.75762.b0","article-title":"Arterial stiffness and kidney function","volume":"43","author":"Safar","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.kint.2023.05.024_bib54","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/ndt\/gfm542","article-title":"Cardiovascular remodelling and extracellular fluid excess in early stages of chronic kidney disease","volume":"23","author":"Essig","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2023.05.024_bib55","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ki.2013.336","article-title":"Volume overload correlates with cardiovascular risk factors in patients with chronic kidney disease","volume":"85","author":"Hung","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2023.05.024_bib56","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1053\/j.ajkd.2021.09.026","article-title":"Rates of reversal of volume overload in hospitalized acute heart failure: association with long-term kidney function","volume":"80","author":"McCallum","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2023.05.024_bib57","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1097\/HJH.0000000000000281","article-title":"Combinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients: a randomized, controlled trial","volume":"32","author":"Ogihara","year":"2014","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.kint.2023.05.024_bib58","article-title":"Use of antihypertensive agents and association with risk of adverse outcomes in chronic kidney disease: focus on angiotensin-converting enzyme inhibitors and angiotensin receptor blockers","volume":"7","author":"Ku","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.kint.2023.05.024_bib59","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/MNH.0b013e32832eb7fb","article-title":"Should diuretics always be included as initial antihypertensive management in early-stage CKD?","volume":"18","author":"Segura","year":"2009","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.kint.2023.05.024_bib60","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1053\/j.ajkd.2004.01.009","article-title":"Achievement of target blood pressure levels in chronic kidney disease: a salty question?","volume":"43","author":"De Nicola","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2023.05.024_bib61","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1080\/08860220701641777","article-title":"Acute effect of furosemide on glomerular filtration rate in diastolic dysfunction","volume":"29","author":"Trivedi","year":"2007","journal-title":"Ren Fail"},{"key":"10.1016\/j.kint.2023.05.024_bib62","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1042\/cs0680255","article-title":"Mechanism of increased plasma urea after diuretic therapy in uraemic patients","volume":"68","author":"Dal Canton","year":"1985","journal-title":"Clin Sci"},{"key":"10.1016\/j.kint.2023.05.024_bib63","doi-asserted-by":"crossref","first-page":"398","DOI":"10.7326\/M18-3079","article-title":"Graphical depiction of longitudinal study designs in health care databases","volume":"170","author":"Schneeweiss","year":"2019","journal-title":"Ann Intern Med"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253823004180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253823004180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:05:00Z","timestamp":1758762300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253823004180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0085253823004180"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2023.05.024","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A nationwide cohort study comparing the effectiveness of diuretics and calcium channel blockers on top of renin-angiotensin system inhibitors on chronic kidney disease progression and mortality","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2023.05.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}